Conditions: Type 1 Diabetes Mellitus
Keywords: type 1 diabetes mellitus
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 5
Healthy volunteers: no

Brief summary:
This study will assess the safety and efficacy of secukinumab on the preservation of pancreatic beta cells in patients with newly-diagnosed type 1 diabetes mellitus.

Detailed description:

Arms:
arm 1: Secukinumab will be delivered as part of an induction regimen followed by a maintenance regimen for up to 1 year arm 2: Placebo will be delivered as part of an induction regimen followed by a maintenance regimen for up to 1 year

Interventions: intervention 1: Secukinumab intervention 2: Placebo
Intervention descriptions: intervention 1: None intervention 2: Placebo

Protocol document: